Expanding Adult-Use And Medical Cannabis Markets Will Redefine The Industry

Published
02 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
CA$1.88
27.0% undervalued intrinsic discount
15 Aug
CA$1.37
Loading
1Y
-39.9%
7D
33.0%

Author's Valuation

CA$1.9

27.0% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Decreased 24%

Shared on24 Apr 25
Fair value Decreased 0.40%

AnalystConsensusTarget has increased profit margin from 0.7% to 1.1% and decreased future PE multiple from 293.7x to 186.5x.

Shared on17 Apr 25
Fair value Increased 19%

AnalystConsensusTarget has increased discount rate from 7.3% to 8.1%.

Shared on09 Apr 25